methodology used in immunologynjms.rutgers.edu/gsbs/olc/mci/prot/2009/gradimmuno2009... ·...
TRANSCRIPT
MethodologyMethodology
used in used in
ImmunologyImmunology
Antigen reacts with antibody to form an aggregate or precipitate
Equivalent concentration of antigen & antibody forms a precipitate
The Precipitin Reaction
Blood TypingBlood Typing
If the Rh antigen is also present, the person is RhIf the Rh antigen is also present, the person is Rh++, if they , if they do not have the Rh antigen, they are Rhdo not have the Rh antigen, they are Rh--
CoombsAnti-globulin testHemolytic anaemia
Detects anti-Rh antibody (IgG)
Direct and Indirect
human
Enzyme Linked Immuno Sorbent Assay
Antigenic site = epitope = Antigenic determinant 1° Antibody can be polyclonal or monoclonalMUST be Specific binding
Enzyme Linked Immuno Sorbent Assay
Antibody used for detection isLabeled with biotinBiotin binds to streptavidin that is linked to an enzyme (HRP)
HRP catalyzes the substrate (NBT/BCIP) to yield a color.
Colorimetric detection
Detection of DIG-labeled nucleotides/antibody is done using anti-DIG antibodies conjugated to alkaline phosphatase.
When a substrate such as CSPD (dioxetane) is added, alkaline phosphatase breaks down the substrate, which emits a photon of light.
Fluorescently-tagged DNA probes or antibodies have the advantage that no enzymatic reaction is necessary for detection. Dye-conjugated nucleotides are incorporated into DNA during labeling eg. PCR labeling.
Antinuclear antibodies ANAAntinuclear antibodies ANAThey are auto-antibodies against nuclear components that can be detected by indirect immunofluorescence on cell nuclei.
The diffuse staining pattern is the commonest, associated with SLEThe speckled pattern is associated with Mixed Connective Tissue Disease The nucleolar pattern is associated with sclerosisAnticentromere staining is associated with a subgroup of sclerosis
The ELISPOT assay
Variation of ELISA
Quantitates the number of cells producing antibodies
Identifies cells producing specific cytokines
Western Blot
for detection of anti HIV antibodies
C + Neg
A positive test shows the presence of p24 AND either gp 120 or gp 160
Immunoprecipitation
For detection of proteins using specific antibodies
• Using an antibody to isolate and purify a protein from a whole cell lysate.
• Normally you will only purify the protein the antibody recognizes.
• Any additional proteins that co-purify are candidates for interacting proteins.
Immunoprecipitation
• affinity purification based on isolation of Ag-Ab complexes
• analyze by gel electrophoresis
• isolation of Ag-Ab complexes
Bacterial proteins that bind IgG (Fc):• protein A (Staphylococcus aureus)• protein G (Streptococcus)
• binds more species and subclasses
Separation of Cells on a Ficoll Hypaque density gradient
Separation of cells using magnetic beads
Mouse Spleen
Magneticcolumn Other cells CD45 Cells
Magnetic beads coated with anti CD45 antibody
Immunofluorescence and Immunohistochemistry
PBMC stained withAnti IL-2 FITC
PBMC stained withAnti IL-2 Peroxidase/DAB
IL-2 producing cellsStained in situ
Flow Cytometry
Light Scatter Gating
90 Degree Scatter0 200 400 600 800 1000
Forw
ard
Sca
tter
0 2
00 4
00 6
00 8
0010
00
Lymphocytes
Monocytes
Neutrophils
Side Scatter Projection
(measures complexity)
(mea
sure
s siz
e)
8
15
20
30
40
50
100
200
1000
Scale
CD45 vs SS
Normal
Loss of CD4+ T cellsHIV ??
Immunophenotype of a patient with CLL
CD19+ and Ig kappa +Indicating B cell monoclonality
Mostly CD45+Indicating leukocytesCD14 -No monocytes
Mostly CD23+ B cells(also excludes mantle cell)
CD5+ and CD20+Indicating CD5+ B lymphocytes
EARLY B-CELL CD19 51.8 % PAN B CD20 49.3 % CD20 INTENSITY 2+PAN T/B CLL CD5 85.5 % CD19+/CD5+ CELLS 41.4 % ACTIVATED B-CELL CD23 44.5 %
SIG KAPPA 97.5 % SIG LAMBDA 0.5 %
CD38 60.0 % CD19+/CD38+ 60.6 %CD79b 20.5 % B SUBSET, FMC-7 9.6 % CALLA CD10 0.6 %CD19+/CD10+ CELLS 0.5 %
T-CELL ANTIGEN CD3 46.2 %
INTERPRETATION B-cells express CD5, CD19, CD20, CD23 and monotypic immunoglobulin KAPPA light chain, c/w B-CLL/SLL.
FLOW CYTOMETRY - Lymph Node, FNA
41.1 %
0 200 400 600 800 1000SSC-Height
10 0 10 1 10 2 10 3 10 4CD19 FITC
10.4 %
44.1 %
10 0 10 1 10 2 10 3 10 4KAPPA FITC
10 0 10 1 10 2 10 3 10 4LAMBDA PE
CD
19 P
ER
CP
CD
19 P
ER
CP
CD
5 PE
F SC
- Hei
g ht
expression of kappa & lambda in CD19+/CD5+ lymphocytes
41.4%
Fluorescence Activated Cell Sorting
Some Applications of Flow Cytometry
Surface antigens.• Lymphocyte sub-sets.• Immunophenotyping : peripheral blood & bone marrow. • Leukemia diagnosis• Stem cell counting. (CD34).• Cytokine receptors & intracellular flow cytometry
DNA Analysis (Ploidy)
Apoptosis
Cell Cycle and DNA analysis
DNA Ploidy
Detection of Apoptosis using Annexin V
Normal cellApoptotic cell
Detection of Apoptosis using Annexin V
Detection of Apoptosis by
TUNEL
Functional assays for lymphocytes
Measurement of Cell Proliferation
Measurement of Cytotoxicity
Hemacytometer: Use 10XUse 10Xobjectiveobjective
1 2
3 4
5
Count the number of cells in squares 1Count the number of cells in squares 1--4; determine average # cells/square4; determine average # cells/squareAverage # cells/square X 10Average # cells/square X 1044 = # cells/ml= # cells/ml
Parameter Methods
Phagocytosis Migration and chemotaxis, detection of respiratory burst
Lymphocyte subsets
Flow cytometry, immunohistochemistry
Lymphocyte activity
Lymphocyte proliferation test, Cytotoxicity assay, mixed lymphocyte reaction
Cytokines Bioassay, ELISA, PCR
Immunoglobulin levels
Radial immunodiffusion RID, ELISA
Complement Hemolytic activity, ELISA
CRP, lysozyme and other humoral factors
ELISA, turbidimetry
•Immunoassays (e.g., ELISA)
•Protein-protein interaction assays (e.g., interaction mapping)
•Enzyme assays (e.g., kinase, phosphatase, and protease assays)
•Receptor-ligand assays
•Protein-nucleic acid assays
Liquid Bead arrays
The Luminex machine
Luminex Multiplexed Assay Principle
UCUCSSFF
5.6 micron polystyrene beads internally dyed with red and infrared fluorophores.
100 bead sets available, each with different dye ratios and each with a unique spectral signature determined by its red/infrared ratio.
Capture reagents (e.g., antibodies, oligos, peptides, receptors) chemically coupled to beads.
Small size/surface area and 3-dimensional exposure of the beads allows for nearly solution-phase kinetics.
The red laser identifies which assay is carried on the bead, while the green laser quantifies the analyte.
Principles of the Luminex Technology
The Microsphere is a 5.6mM polystyrene bead with two fluorescent dyes incorporated into it in different ratios.
The Microsphere is a 5.6mM polystyrene bead with two fluorescent dyes incorporated into it in different ratios.
A primary antibody specific for the analyte isconjugated to the bead surface by an amine coupling reaction
A primary antibody specific for the analyte isconjugated to the bead surface by an amine coupling reaction
The primary antibody binds to the specific analyte – no crossreactivity with other analytes occurs.
The primary antibody binds to the specific analyte – no crossreactivity with other analytes occurs.
A biotinylated, analyte specific reporter antibody is added to the assay after another wash step.
A biotinylated, analyte specific reporter antibody is added to the assay after another wash step.
After another wash step Streptavidin PE is added to the assay. The biotinylated reporter antibody binds to one of the four available sites.
After another wash step Streptavidin PE is added to the assay. The biotinylated reporter antibody binds to one of the four available sites.
In assays with high analyte numbers excess biotinylated reporter antibodies bind to the Strep-PE in a non-specific manner.
In assays with high analyte numbers excess biotinylated reporter antibodies bind to the Strep-PE in a non-specific manner.
Free excess streptavidin-PE binds to the non-specifically bound biotinylated reporter antibody leading to a signal amplification.
Free excess streptavidin-PE binds to the non-specifically bound biotinylated reporter antibody leading to a signal amplification.
The phycoerythrin is excited by the reporter laser and emits a fluorescence which is quantified by the Luminex reader.
The phycoerythrin is excited by the reporter laser and emits a fluorescence which is quantified by the Luminex reader.
The immune-complex/ microsphere is then excited by the ****** laser. The bead specific emmission is quantified by the luminex and the bead identified.
The immune-complex/ microsphere is then excited by the ****** laser. The bead specific emmission is quantified by the luminex and the bead identified.
Beadlyte Immunoassay format for the Luminex Machine.
TSPE Reaction•TSPE primers are chimeric oligos with a virus-specific sequence and Tag sequence complimentary to anti-Tag sequence bound to microbead
•TSPE primers are extended by Taq polymerase and incorporate biotin reporter molecule
•Biotinylated amplicons are detected with a fluorescent SA-Phycoerythrin conjugate and signals are read using the Luminex instrument
Tag Anti-Tag>
BiotinBiotin
Bead Hybridization
Cytokines
UCUCSSFF
Aβ 40 Aβ 42 BDNF DR-5 EGF ENA-78 Eotaxin Fatty Acid Binding Protein FGF-basic G-CSF GCP-2 GM-CSF GRO αGRO-KC HGF I-TAC ICAM-1 IFN-αIFN-γ
IL-1αIL-1βIL-1ra IL-1ra/IL-1F3 IL-2 IL-3 IL-4 IL-5 IL-6 IL-7 IL-8 IL-9IL-10 IL-11IL-12 p40/p70 IL-13 IL-15 IL-16 IL-17 IL-18 IP-10
JE/MCP-1 KC KC/GROa LIF Lymphotacin M-CSF MCP-1 MCP-1(MCAF) MCP-2 MCP-3 MCP-5 MDC MIG MIP-1αMIP-1βMIP-1γMIP-2 MIP-3 βOSM PDGF-BB RANTES
Rb (pT821) Rb (total) Rb pSpT249/252 Tau (pS214) Tau (pS396) Tau (total) Tissue Factor TNF-αTNF-βTNF-RI TNF-RII TNF-SF5 VCAM-1 VEGF
Immune Cell Function Test
• Measures the Net State of Immune Function –based on lymphocyte proliferation assay.
•Used to MonitorTherapy Response
Immune Function is Independent of CD4 Count
LuminometerATPATP ATPATP
ATPATP
Cell lysis to release ATP
ATP detection reagents
Measure light intensity
LymphocyteStimulation w/PHA
WashIncubate
15-18 hrs.
Magnetic separationof CD4 cells.
J. Britz et. al.,“In Vitro CMI: Rapid Assay for Measuring Cell-Mediated Immunity”, CRC Press, 2002
Immuknow
ImmuKnow™: Stratification of Immune Response
Kowalski, R. et. al., Clinical Transplantation:17:77-88, 2003
FDA Claim: ImmuKnow™ is used for the detection of cell-mediated immunity in an immunosuppressed population.
Strong
Low
Moderate
Healthy Adults Stable Transplant Recipients
I mm
un
e R
esp o
ns e
(A
T P n
g /m
L)
0
200
400
600
800
415
258
(n=155) (n=127)
P < 0.0001
Immune Function Correlates With Clinical Outcomes
Healthy StableRejection Infection
Imm
un
e R
espo
nse
(A
TP n
g/m
L)
0
200
400
600
800
1000
415
249
488
111
Strong
Low
Moderate
(n=155) (n=39) (n=504) (n=66)
P < 0.001
P < 0.001
Meta-Analysis: NIDDK, UCLA, JHU, UPMC, NZTI, LifeLink, UTMB, UAB, UMD, INOVA
THANK YOUTHANK YOU